Abiopharma

VNET Announces Changes to Leadership Team

M2i Global, along with Volato Group, and Regenerate Technology Global Execute Strategic Partnership to Advance Battery Recycling Technologies to the U.S.

Enlight to Report First Quarter 2026 Financial Results on Tuesday, May 5, 2026

Mammoth Announces First-Quarter 2026 Conference Call

Calidi Biotherapeutics Presents New Data on Its Differentiated Approach to In Situ T-Cell Engagers Including a New Candidate Targeting TROP-2 at the AACR Annual Meeting in April 2026

LENZ Therapeutics Announces Submission of Marketing Authorization Application to the Medicines and Healthcare products Regulatory Agency for VIZZ® for the Treatment of Presbyopia in the United Kingdom

Acurx Pharmaceuticals to Discuss First Quarter 2026 Financial Results on May 12, 2026 Conference Call and Provide Business Update

Beyond Cancer Reports Updated Survival and Safety Data from Phase 1 UNO Trial Presented at AACR 2026

Hadron Energy Aligns Valuation for Business Combination to $600M, Signaling Long-Term Market Discipline After GigCapital7 Form S-4 Registration Statement Declared Effective

C1 Fund Inc. (NYSE: CFND) Announces Liquidity Event from Ripple Investment, Realizing Approximately 150% Return in Less than Four Months

Axe Compute Unveils Compute Reserve Dashboard, Giving Investors a Unified View of Its NASDAQ Stock and Operational Strategic Compute Reserve

MainStreet Bancshares, Inc. Announces First Quarter 2026 Results

Rayonier Advanced Materials Announces Comprehensive Strategic Alternatives Review to Maximize Shareholder Value

Fulcrum Therapeutics to Host First Quarter 2026 Financial Results Conference Call and Webcast on Monday, April 27, 2026, at 8:00 a.m. ET

Leonardo DRS Launches New Maritime Counter-UAS Capability to Defeat Aerial Unmanned Threats at Sea